Analysis of multiple basal cell carcinomas (BCCs) arising in one individual highlights genetic tumor heterogeneity and identifies novel driver mutations

Basal cell carcinoma (BCC) is the most common human cancer, especially in individuals with light skin phototypes (i.e., Fitzpatrick I-II skin type). Many affected develop multiple BCCs during their lifetime. It is not uncommon to observe elderly patients with >5 BCCs. In this study, we explored whether for patients diagnosed with multiple BCCs, analyzing the genomic mutations in one tumor could be sufficient to derive meaningful molecular/genetic conclusions regarding the other BCC tumors. Following the Genome Analysis Toolkit (GATK) best practices we have completed the study of 6 BCCs that occurred in an 83-year-old Caucasian male due to sun exposure. We have analyzed exome sequencing data of each BCC tumor and matched normal skin samples. We identified that BCCs from the same patient shared some of the key driver mutations, but they also displayed significant intertumoral heterogeneity. This finding may in part explain the different clinical progression/evolution of BCCs observed in the same patient. This work also highlights the value of characterizing multiple BCCs in one individual to identify patient-specific genetic events with a potential link to other malignancies and implications for personalized medicine.     

Advances in the design of special cryosurgical apparatus in China

Advances in the design of special cryobiomedical apparatus and a review of the trend of developments in the field of cryosurgery in China are discussed. The typical structure of two special cryoprobes for treatment deep in the body and the technology of designing these probes are presented in detail. Some cases which are treated successfully with the above cryoprobes will also be discussed. The experimental aspects of heat transfer in frozen tissue and of the temperature profiles both of a human brain during surgery and of the cryoprobe are described. Other improvements in the field of cryosurgical devices, e.g., four main ways of attaching freezing tips to cryoprobes during surgery and an LN2 transfer tube with high dexterity are also presented. Finally, the development of commercial cryosurgical apparatus in China is also discussed.     

酶联免疫吸附技术(ELISA)对大豆根瘤菌的鉴定

本文用直接ELISA法检测大豆根瘤菌USDA 110和RTt 50的纯培养菌体和根瘤。确定了该试验的最佳工作条件:酶标结合物HRP—Ab 110和HRP—Ab50的工作稀释度分别为1:3200和1:800,抗体Ab 110和Ab 50的工作稀释度分别为1:3200和1:800,抗原USDA 110和RTt 50的最适工作浓度均为6×10~7细胞/ml。该法能够特异地检测和区别慢生型和快生型大豆根瘤菌。在这两种类型的大豆根瘤菌中,同种内的少数菌株存在交叉反应,通过吸收可以消除,从而使ELISA的检测达到菌株     

ABA与植物胁迫抗性

ABA是一种重要的植物激素,受到生物胁迫和非生物胁迫的调控,在植物对胁迫耐受性和抗性中发挥着重要作用。本文着重阐述了植物胁迫对ABA的生物合成和代谢的调控、ABA在调控气孔关闭和调控基因表达从而调控植物耐逆性方面的作用,以及植物胁迫信号转导途径间的联系和交叉。     

微乳体系中11β-羟基甲羟孕酮的C1,2生物脱氢

为改善过程传质,提高甾类药物中间体11β-羟基甲羟孕酮C1,2生物脱氢转化率,采用简单节杆菌Arthrobacter simplex UR016菌株在Tween-80/乙醇/食油/水构成的微乳体系中进行生物脱氢,并考察了微乳体系组成、转化温度、投料浓度对脱氢反应的影响。结果表明:以菌体培养液作为水相,食油作为油相构建微乳体系,食油最适加量为10g/L,表面活性剂Tween-80加量为4g/L;底物经醇溶后水析投料,乙醇最适加量为发酵液体积的7%(V/V);最适转化温度为33oC;当底物浓度为4g/L时,在构建的微乳体系中转化46h,脱氢转化率达88.6%,与水相转化工艺相比提高了66.2%。在该体系中疏水性11β-羟基甲羟孕酮底物得到了有效的增溶和扩散,生物脱氢转化率明显提高。     

Valuing urban green spaces in mitigating climate change: A city‐wide estimate of aboveground carbon stored in urban green spaces of China's Capital

Urban green spaces provide manifold environmental benefits and promote human well‐being. Unfortunately, these services are largely undervalued, and the potential of urban areas themselves to mitigate future climate change has received little attention. In this study, we quantified and mapped city‐wide aboveground carbon storage of urban green spaces in China's capital, Beijing, using field survey data of diameter at breast height (DBH) and tree height from 326 field survey plots, combined with satellite‐derived vegetation index at a fine resolution of 6 m. We estimated the total amount of carbon stored in the urban green spaces to be 956.3 Gg (1 Gg = 10⁹ g) in 2014. There existed great spatial heterogeneity in vegetation carbon density varying from 0 to 68.1 Mg C ha^‐1, with an average density of 7.8 Mg C ha^?1. As expected, carbon density tended to decrease with urban development intensity (UDI). Likely being affected by vegetation cover proportion and configuration of green space patches, large differences were presented between the 95th and 5th quantile carbon density for each UDI bin, showing great potential for carbon sequestration. However, the interquartile range of carbon density narrowed drastically when UDI reached 60%, signifying a threshold for greatly reduced carbon sequestration potentials for higher UDI. These findings suggested that urban green spaces have great potential to make contribution to mitigating against future climate change if we plan and design urban green spaces following the trajectory of high carbon density, but we should be aware that such potential will be very limited when the urban development reaches certain intensity threshold.     

Aromatic‐interaction‐mediated inhibition of β‐amyloid assembly structures and cytotoxicity

Abnormal aggregation of β‐amyloid (Aβ) peptide plays an important role in the onset and progress of Alzheimer's disease (AD); hence, targeting Aβ aggregation is considered as an effective therapeutic strategy. Here, we studied the aromatic‐interaction‐mediated inhibitory effect of oligomeric polypeptides (K8Y8, K4Y8, K8W8) on Aβ42 fibrillization process. The polypeptides containing lysine as well as representative aromatic amino acids of tryptophan or tyrosine were found to greatly suppress the aggregation as evaluated by thioflavin T assay. Circular dichroism spectra showed that the β‐sheet formation of Aβ42 peptides decreased with the polypeptide additives. Molecular docking studies revealed that the oligomeric polypeptides could preferentially bind to Aβ42 through π–π stacking between aromatic amino acids and Phe19, together with hydrogen bonding. The cell viability assay confirmed that the toxicity of Aβ42 to SH‐SY5Y cells was markedly reduced in the presence of polypeptides. This study could be beneficial for developing peptide‐based inhibitory agents for amyloidoses. Copyright © 2017 European Peptide Society and John Wiley & Sons, Ltd.